■ Is it the time for laparoscopic management of early-stage ovarian malignancies?

Tantitamit T, Lee CL.

Gynecol Minim Invasive Ther. 2018 Jul-Sep;7(3):93-103

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135162/

 

■ Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: Which is the optimal adjuvant chemotherapy regimen?

Lee MX, Tan DS.

J Gynecol Oncol. 2018 Nov;29(6):e96

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189442/

 

■ Checkpoint-inhibition ovarian cancer: Rising star or just a dream?

Pietzner K, Nasser S, Alavi S, Darb-Esfahani S, Passler M, Muallem MZ, Sehouli J.

J Gynecol Oncol. 2018 Nov;29(6):e93

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189441/

 

■ Is pap testing still needed after hysterectomy?

H G Sobel, E Everett, L D Lipold

Cleveland Clinic Journal of Medicine 2018, vol 85 (6): 456-458

https://www.mdedge.com/ccjm/article/166682/womens-health/pap-testing-still-needed-after-hysterectomy

 

■ Is postmenopausal endometrial fluid collection alone a risk factor for endometrial cancer?

Gulin Feykan Yegin Akcay, Emre Erdem Tas, Ayse Filiz Yavuz

Pak J Med Sci. 2018, vol 34(1): 54–57

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857029/

 

■ Endometrial cancer – How many patients could benefit from sentinel lymph node dissection

Sarah Brugger, Moritz Hamann, Marc Mosner et al

World J Surg Oncol. 2018; 16: 95

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956846/

 

■ The next generation of cervical cancer screening: Should guidelines focus on best practices for the future or current screening capacity?

Castle, Phil; Feldman, Sarah; Perkins, Rebecca B.

Journal of Lower Genital Tract Disease 2018, vol 22(2):91-96

https://journals.lww.com/jlgtd/Fulltext/2018/04000/The_Next_Generation_of_Cervical_Cancer_Screening__.2.aspx

 

■ Is it time to move beyond visual inspection with acetic acid for cervical cancer screening?

Shannon L. Silkensen, Mark Schiffman, Vikrant Sahasrabuddhe, John S. Flanigan

Glob Health Sci Pract. 2018, vol 27; 6(2): 242–24

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024629/

 

■ Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: Is less radiation equal to more?

Chiachien Jake Wang, Alana Christie, Michael R. Folkert et al

J Gynecol Oncol. 2018 Jul; 29(4): e49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981101/

 

■ Are patients and physician willing to accept less-radical procedures for cervical cancer?

Kemal Gungorduk, Roman Kocian, Derman Basaran et al

J Gynecol Oncol. 2018 Jul; 29(4): e5

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981102/

 

■ Equal management of equal risks: What should be used as the standard for cervical cancer prevention?

Walter K. Kinney, Rebecca B. Perkins, George F. Sawaya

J Low Genit Tract Dis. 2018 Jul; 22(3): 237–24

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023600/

■ Are vaginal swabs compared to cervical smears for human papillomavirus DNA testing?

Liselotte Coorevits, Ans Traen, Luc Bingé, Jo Van Dorpe et al

J Gynecol Oncol. 2018 Jan; 29(1): e8

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709534/

 

■ Carcinoma do endométrio e estadiamento cirúrgico: ressonância magnética ou estudo extemporâneo?.

Gallego, José Carlos.

Acta Obstet Ginecol Port, Jun 2018, vol.12, no.2, p.160-16

http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S1646-58302018000200012&lng=pt&nrm=iso

 

■ Persistent inflammatory pap smears: There will be obligation to refer?.

Santos, Fernanda and Pacheco, Amália

Acta Obstet Ginecol Port, Mar 2018, vol.12, no.1, p.28-35

http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S1646-58302018000100005&lng=pt&nrm=iso

 

■ Fertility preservation healthcare circuit and networks in cancer patients worldwide: What are the issues?

Kathleen Melan, Frederic Amant, Jacqueline Veronique-Baudin et al

BMC Cancer. 2018; 18: 192

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816557/

 

■ How should gynecologic oncologists react to the unexpected results of LACC trial

Jeong-Yeol Park, Joo-Hyun Nam

J Gynecol Oncol. 2018 Jul; 29(4): e74

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981115/

 

by Dr Paulo Fernando Leite

■ Cardiologia/Prevenção Cardiovascular

■ Estratificação de Risco Cardiovascular

Av Contorno 8351 – Conj 01

Belo Horizonte/MG/Brasil

Tel: 31 32919216   2917003   3357229

(- consulta particular –)

CRMMG: 7026

Email: pfleite1873@gmail.com